Cart
sales@molnova.com
CCG-224406
CAS No. 1870843-22-3
CCG-224406( CCG 224406 | CCG224406 )
Catalog No. M12895 CAS No. 1870843-22-3
A highly selective and potent GRK2 (G protein-coupled receptor kinase 2) inhibitor with IC50 of 130 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCCG-224406
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly selective and potent GRK2 (G protein-coupled receptor kinase 2) inhibitor with IC50 of 130 nM.
-
DescriptionA highly selective and potent GRK2 (G protein-coupled receptor kinase 2) inhibitor with IC50 of 130 nM; displays >700-fold selectivity over other GRK subfamilies, and no detectable inhibition of ROCK1.
-
In Vitro——
-
In Vivo——
-
SynonymsCCG 224406 | CCG224406
-
PathwayOthers
-
TargetGRK (GPCRK)
-
RecptorGRK (GPCRK)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1870843-22-3
-
Formula Weight558.57
-
Molecular FormulaC29H27FN6O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC(C2=CC=C(F)C(C(NCC3=C(OC)C=CC=C3OC)=O)=C2)C(C(NC4=CC5=C(C=C4)NN=C5)=O)=C(C)N1
-
Chemical Name4-(3-((2,6-dimethoxybenzyl)carbamoyl)-4-fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Waldschmidt HV, et al. J Med Chem. 2016 Apr 28;59(8):3793-807.
molnova catalog
related products
-
CCG-215022
CCG-215022 (CCG215022) is a potent and selective pan GRK inhibitor with IC50 of 0.15/0.38/3.9 uM for GRK2/5/1 respectively.
-
GRK2i
GRK2 inhibitory polypeptide that specifically inhibits Gβγ activation of GRK2. Corresponds to the Gβγ-binding domain and acts as a cellular Gβγ antagonist.
-
GRK5-IN-2
GRK5-IN-2, a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. It regulates the expression and/or release of insulin and is useful for the metabolic disease research.
